Study of Lamotrigine to Treat Ménière's Disease

Inclusion Criteria: * Male and female participants aged 18 years or older * Diagnosed with unilateral definite Ménière's disease according to the AAO-HNS 1995 criteria, confirmed by an ENT * Active vertigo: at least two Ménière's vertigo attacks (defined as lasting 20 minutes or longer and associated with tinnitus, ear fullness, or low frequency hearing loss and nausea/vomiting) every four weeks during the eight-week qualification period and at least two more Ménière's vertigo attacks during the lead-in phase prior to randomization * Documented unilateral lower frequency hearing loss defined as the four-tone average (arithmetic mean rounded to the nearest whole number) of the pure-tone thresholds at 0.25, 0.5, 1 and 2 kilohertz (kHz) more than or equal to 25 decibels (dB) of the worse audiogram during the six months before screening * Have tried diuretics for at least one month and discontinued treatment due to continued vertigo attacks * All other co-existing medical or psychiatric conditions are stable, and no greater than moderate severity * Willing to avoid pregnancy during the entirety of the study (abstinence or two forms of acceptable birth control, such as condoms and oral contraceptives) Exclusion Criteria: * Bilateral Ménière's disease * Current or past history of migraine * Any other neuro-otologic disease or major vestibular abnormality found during screening that could confound the evaluation of Ménière's symptoms * Previous intolerance or sensitivity to lamot…